Literature DB >> 8549332

Expression of beta 1-integrins on epiphyseal chondrocytes is reduced by ofloxacin.

C Förster1, M Shakibaei, H Schilcher, R Stahlmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549332     DOI: 10.2165/00003495-199500492-00070

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.

Authors:  R Stahlmann; H J Merker; N Hinz; I Chahoud; J Webb; W Heger; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 2.  Quinolones in children. Are concerns over arthropathy justified?

Authors:  R Stahlmann; C Förster; D Van Sickle
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

3.  Behaviour of epiphyseal mouse chondrocyte populations in monolayer culture. Morphological and immunohistochemical studies.

Authors:  K Grundmann; B Zimmermann; H J Barrach; H J Merker
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

4.  Localization of beta 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin.

Authors:  J Dürr; S Goodman; A Potocnik; H von der Mark; K von der Mark
Journal:  Exp Cell Res       Date:  1993-08       Impact factor: 3.905

5.  Modulation of integrin-mediated attachment of chondrocytes to extracellular matrix proteins by cations, retinoic acid, and transforming growth factor beta.

Authors:  R F Loeser
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

6.  Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin.

Authors:  M Enomoto; P S Leboy; A S Menko; D Boettiger
Journal:  Exp Cell Res       Date:  1993-04       Impact factor: 3.905

Review 7.  Quinolone arthropathy--acute toxicity to immature articular cartilage.

Authors:  A W Gough; O B Kasali; R E Sigler; V Baragi
Journal:  Toxicol Pathol       Date:  1992       Impact factor: 1.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.